HB 3551: Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease
APPROPRIATIONS PROJECT by Slosberg
Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease; Provides an appropriation for the Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease. APPROPRIATION: $50,000
Effective Date: 7/1/2021
Last Action: 6/2/2021 - Vetoed by Governor; See SB 2500 (line item 468)
Bill Text: PDF
Last Action: 6/2/2021 - Vetoed by Governor; See SB 2500 (line item 468)
Bill Text: PDF
Additional information is available at myfloridahouse.gov.
-
Bill History
Date Chamber Action 2/9/2021 House • Filed
2/14/2021 House • Referred to Health Care Appropriations Subcommittee
• Referred to Appropriations Committee
• Now in Health Care Appropriations Subcommittee
3/2/2021 House • 1st Reading (Original Filed Version)
4/30/2021 House • See SB 2500 (line item 468)
6/2/2021 • Vetoed by Governor; See SB 2500 (line item 468)
-
HB 3551, Original Filed Version (Current Bill Version) Posted 2/9/2021 at 12:33 PM